{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:47:01Z","timestamp":1777355221200,"version":"3.51.4"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>X-linked lymphoproliferative disease type I (XLP I) is caused by mutations in the <jats:italic toggle=\"yes\">SH2D1A<\/jats:italic> gene and characterized mainly by hypogammaglobulinemia and abnormal response to Epstein-Barr virus with a high predisposition to B-cell non-Hodgkin lymphoma development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Observations:<\/jats:title>\n            <jats:p>In this article, we describe the experience of 2 centers in Belarus and in Russia that follow 3 male patients who were diagnosed with XLP I after lymphoma development and treatment. Three novel mutations c.51G&gt;C (p.E17D), c.192G&gt;T (p.W64C), and c.53insA (p.K18KfsX67) were found in 3 males patients with XLP I. Two of them did not have any signs of immunodeficiency before B-cell non-Hodgkin lymphoma development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>We propose <jats:italic toggle=\"yes\">SH2D1A<\/jats:italic> mutational screening be considered in male patients with or without hypogammaglobulinemia who received rituximab treatment for lymphoma and did not recover immunoglobulin G in a year after B-depleting therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000000815","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T15:08:08Z","timestamp":1488899288000},"page":"e203-e206","source":"Crossref","is-referenced-by-count":7,"title":["Novel Mutations in SH2D1A Gene in X-linked Lymphoproliferative Syndrome, Diagnosed After B-Cell Non-Hodgkin Lymphoma"],"prefix":"10.1097","volume":"39","author":[{"given":"Svetlana O.","family":"Sharapova","sequence":"first","affiliation":[{"name":"Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk Region, Belarus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina S.","family":"Fedorova","sequence":"additional","affiliation":[{"name":"Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk Region, Belarus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga E.","family":"Pashchenko","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Russian Clinical Children\u2019s Hospital, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana S.","family":"Vahliarskaya","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Russian Clinical Children\u2019s Hospital, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina E.","family":"Guryanova","sequence":"additional","affiliation":[{"name":"Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk Region, Belarus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandr A.","family":"Migas","sequence":"additional","affiliation":[{"name":"Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk Region, Belarus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina V.","family":"Kondratenko","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Russian Clinical Children\u2019s Hospital, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga V.","family":"Aleinikova","sequence":"additional","affiliation":[{"name":"Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk Region, Belarus"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jaci.2011.02.047","article-title":"Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies","volume":"127","author":"Rezaei","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2141.2010.08442.x","article-title":"X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma","volume":"152","author":"Rezaei","year":"2011","journal-title":"Br J Haematol"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00431-014-2313-7","article-title":"17-year-old boy with XLP de novo mutation","volume":"173","author":"Overwater","year":"2014","journal-title":"Eur J Pediatr"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s10875-014-0117-1","article-title":"Severe XLP phenotype caused by a novel intronic mutation in the SH2D1A Gene","volume":"35","author":"T\u00f3th","year":"2015","journal-title":"J Clin Immunol"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s10875-015-0194-9","article-title":"Cerebral vasculitis in X-linked lymphoproliferative disease cured by matched unrelated cord blood transplant","volume":"35","author":"Gray","year":"2015","journal-title":"J Clin Immunol"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s10875-014-0083-7","article-title":"XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP","volume":"34","author":"Tangye","year":"2014","journal-title":"J Clin Immunol"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev.med.55.091902.104249","article-title":"Rituximab: expanding role in therapy for lymphomas and autoimmune diseases","volume":"55","author":"Rastetter","year":"2004","journal-title":"Annu Rev Med"},{"key":"R9-20230918","first-page":"3118","article-title":"Correlation of mutations of the SH2D1A gene and Epsteinbarr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease","volume":"96","author":"Sumegi","year":"2000","journal-title":"Blood"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"E85","DOI":"10.1002\/pbc.24525","article-title":"Frequent mutations in SH2D1A (XLP) in males presenting with high-grade mature B-cell neoplasms","volume":"60","author":"Sandlund","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.aller.2015.01.007","article-title":"Study of SH2D1A gene mutation in paediatric patients with B-cell lymphoma","volume":"43","author":"Koochakzadeh","year":"2015","journal-title":"Allergol Immunopathol (Madr)"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1182\/blood-2011-01-328849","article-title":"Human X-linked variable immunodeficiency caused by a hypomorphic mutation in XIAP in association with a rare polymorphism in CD40LG","volume":"118","author":"Rigaud","year":"2011","journal-title":"Blood"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201705000-00031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:35:24Z","timestamp":1695011724000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201705000-00031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000815","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}